Insmed, Inc. vs Abbvie Inc.
INSM vs ABBV — side-by-side comparison from reported financials. INSM leads 2, ABBV leads 4 of 6 comparable metrics.
Insmed, Inc.
INSM · Healthcare
$100.50+0.02%Strained
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | INSM | ABBV |
|---|---|---|
| Price | $100.50 | $276.43 |
| Market cap | $21.9B | $488B |
| Revenue (TTM) | — | $64.4B |
| Revenue growth | +35.2% | +1.8% |
| Net margin | — | 9.8% |
| Free cash flow | -$808M | $18.2B |
| Net cash (debt) | $889M | ($56.2B) |
| 1-year price return | -38.9% | +19.8% |
| P/E | — | 77.4 |
| P/E vs own history (cheap-side %) | — | 23% |
| Dividend yield | — | 2.45% |
| Return on equity | -111% | 96% |
| Altman Z-score | — | 2.33 |
| CV checks passed | 3 of 9 | 9 of 9 |
| Employees | 1,664 | 57,000 |
Full résumé-style profiles: INSM CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.